With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:
Corporate Travel Management Ltd (ASX: CTD)
According to a note out of Macquarie, its analysts have upgraded this corporate travel specialist’s shares to an outperform rating with an improved price target of $20.75. The broker made the move amid signs of a strengthening recovery in travel, particularly in the United States, Australia, and New Zealand. It appears optimistic that this will continue thanks to the rapid vaccine rollout in the U.S. and falling numbers of COVID cases. This has led to Macquarie lifting its revenue forecasts for the coming years. The Corporate Travel Management share price is fetching $20.05 today.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
A note out of Credit Suisse reveals that its analysts have retained their outperform rating and lifted their price target on this medical device company’s shares to $34.00 ahead of its full year results release. Credit Suisse is forecasting a result well ahead of the company’s guidance it gave with its half year results. This is expected to be driven by rapid growth from COVID-19 related sales. The Fisher & Paykel Healthcare share price is trading at $31.18.
Northern Star Resources Ltd (ASX: NST)
Another note out of Macquarie reveals that its analysts have retained their outperform rating and increased the price target on this gold mining giant’s shares to $13.30. The broker lifted its price target to account for an increase in the valuation of several of its operations. This offset a reduction in its earnings per share estimates. The Northern Star share price is currently fetching $11.32.